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A unique subpopulation of spleen dendritic cells
(DCs) that express the CD8 surface marker efficiently
present phagocytosed antigens to CD8+ T lympho-
cytes in a process called ‘‘crosspresentation,’’ which
initiates cytotoxic immune responses. We now show
that the small GTPase Rac2 plays a critical role in
antigen crosspresentation selectively in this DC
subpopulation. In CD8+ DCs, Rac2 determines the
subcellular assembly of the NADPHoxidase complex
(NOX2) to phagosomes, whereas in CD8 DCs, Rac1
mediates the assembly of NOX2 at the plasma
membrane. In the absence of Rac2, the production
of reactive oxygen species (ROS) in DC-phagosomes
was abolished, the phagosomal pH dropped, and the
efficiency of antigen crosspresentationwas reduced.
We conclude that the activity of Rac1 and 2 control
crosspresentation in DC subpopulations through the
regulation of phagosomal oxidation and pH.
INTRODUCTION
Antigen processing and presentation determine the specificity of
immune recognition during adaptative immune responses.
Dendritic cells (DCs) are the most potent initiators of T cell-medi-
ated immune responses, at least in part because of their unique
capacity for antigen processing and presentation. Unlike other
antigen-presenting cells, after antigen phagocytosis, DCs
present antigenic peptides on both MHC class I and class II mole-
cules and efficiently activate both CD4+ and CD8+ T cells. DCs
are particularly efficient, as compared to other antigen-present-
ing cells, for the presentation of phagocytosed antigens to
CD8+ T cells, a process called ‘‘crosspresentation’’ (Bevan,
1976). The molecular mechanisms that make DCs such a unique
antigen crosspresenting cell are still unclear. Several recent
studies, however, showed that DCs have adapted their endocytic544 Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc.and phagocytic pathways to the crosspresentation function.
These adaptations seem to concur to limit the proteolytic activity
in endosomes and phagosomes of DCs (Jancic et al., 2007;
Savina et al., 2006). In several experimental settings in vitro and
in vivo, low proteolytic activity in the internalization pathway
correlates with high antigen crosspresentation, and vice versa.
The mechanisms that limit endo-phagocytic proteolysis in
DCs include low expression levels and low recruitment of proteo-
lytic enzymes to phagososmes (Lennon-Dumenil et al., 2002),
limited acidification by the V-ATPase (Trombetta et al., 2003),
and active alkalinization of the endosomal and phagosomal
lumen by the NADPH oxidase NOX2 (Savina et al., 2006).
Thus, after internalization in DCs, antigens are exposed to
a nearly neutral pH, oxidative, lowly proteolytic milieu. This is in
marked contrast to what happens in macrophages or neutro-
phils, the two types of phagocytes in which phagocytosis has
been analyzed in some detail. In macrophages, the phagosomal
pH drops to values around 5.5 in the first 30 min after engulfment
(Lukacs et al., 1990; Yates et al., 2007). The proteolytic activity is
extremely high and most proteins are rapidly degraded into
amino acids. In neutrophils, a transient and alkalinization of the
phagosomal pH results in a subsequent cascade of ionic fluxes
that activates proteolytic enzymes before the pH acidifies
strongly (Jiang et al., 1997; Reeves et al., 2002). Here too,
proteins are rapidly degraded into amino acids. The results pub-
lished thus far suggest that DCs limit their endo-phagosomal
proteolytic capacity to ‘‘preserve’’ peptides from complete
degradation. These ‘‘protected’’ peptides could then be loaded
on MHC molecules and serve as a basis for immune recognition.
One of the main limitations with the studies analyzing phago-
cytic functions in DCs is that they have mainly been performed
with in vitro generated DCs (from the bone marrow, in general).
Very little, in contrast, is known about the DCs that reside in
lymphoid organs. In both spleen and lymph nodes, murine DCs
can be divided into several subpopulations via different surface
markers (Vremec et al., 1992). One of these subpopulations
expresses CD8aa homodimers and is referred to as ‘‘CD8+’’
DCs. This subpopulation was shown in many different experi-
mental systems to crosspresent antigens more efficiently than
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et al., 2002; Pooley et al., 2001; Schnorrer et al., 2006; Schulz
and Reis e Sousa, 2002).
We have analyzed the phagocytic pathway in these two main
DC subpopulations of the spleen. In CD8–, but not in CD8+,
DCs, phagosomes acidified in the first hours of phagocytosis.
High phagosomal pH was maintained in CD8+ DC phagosomes
by the assembly of the NADPH oxidase NOX2 cytosolic subunits
(including p47phox) to the membrane subunits (gp91phox and
gp22phox). Phagosomal assembly of the complex in CD8+ DCs
caused the production of ROS inside phagosomes and prevented
acidification. In CD8– DCs, in spite of very high amount of total
ROS production, no phagosomal assembly of NOX2 or produc-
tion of ROS was observed. These differences in the phagosomal
function in CD8+ and CD8– DCs were, at least in part, because
of Rac2. Indeed, in Rac2-defective DCs, like in gp91phox-defec-
tive DCs, the production of ROS, the phagosomal pH, and the
crosspresentation capacities were all similar in CD8+ and CD8–
spleen DCs.
RESULTS
NOX2 Alkalinizes Phagosomes and Endosomes in CD8+
but Not in CD8 Spleen DCs
By using bone marrow-derived DCs, we have previously shown
that crosspresentation requires high pH in phagosomes (Jancic
et al., 2007; Savina et al., 2006). In the spleen, crosspresentation
is a specific attribute of a particular DC subpopulation, the CD8+
DCs (Pooley et al., 2001; Schnorrer et al., 2006). In order to deter-
mine the pH in the endo-phagocytic pathway in spleen DC
populations, enriched CD11c+ splenocytes were allowed to
phagocytose latex beads bearing a mixture of pH-sensitive
and -insensitive dyes. The phagosomal pH was measured by
FACS as described previously (Savina et al., 2006). As shown in
Figure 1A (left), phagosomes in CD8+ DCs maintain a pH above
7 during the first hours after phagocytosis. In contrast, the pH
in CD8– phagosomes was more acidic (by more than one pH
unit) than in the CD8+ DC phagosomes.
Because we have already demonstrated that bone marrow-
derived DCs generated in vitro bear a phagosomal NOX2-
dependent alkalinization system for the regulation of the pH
(Savina et al., 2006), we hypothesize that NOX2 could also be
responsible for the high pH in splenic CD8+ phagosomes. We
therefore tested the pH in phagosomes from CD8+ and CD8–
DCs from gp91phox-defective mice (Cybb/ mice). As shown
in Figure 1A (right), the phagosomal pH in NOX2-defective
CD8+ DCs dropped to values similar to the ones found in CD8–
DCs. The phagosomal pH in CD8– DCs, in contrast, was not
appreciably affected in the absence of NOX2. Similar results
were obtained in phagosomes from WT DCs after treatment
with DPI, a potent inhibitor flavin-containing enzymes, such as
NOX2 (Figure 1C). Therefore, NOX2 activity is required to main-
tain the high pH observed in CD8+ DCs phagosomes, but its
absence does not affect phagosomal pH in CD8– DCs.
We also measured the endosomal pH in both cell populations
with fluorescent dextransand FACS-basedapproach on enriched
CD11c+ splenocytes. After 10 min of endocytosis in CD8+ DCs,
the endosomal pH was around 7 (Figure 1B, left). The pH in endo-
somes then acidified slowly, to reach values around 6.5 after 2 hrA
B
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Figure 1. Only CD8+ DCs Alkalinize Their Phagosomes and Endo-
somes in a NOX2-Dependent Manner
(A and B) Enriched WT (left) or Cybb/ (right) CD11c+ splenocytes were
allowed to phagocytose latex beads bearing a mixture of pH-sensitive
and -insensitive dyes (A) or to internalize a mix of fluorescent pH-sensitive
and -insensitive 40 KD dextrans (B). After a pulse and different times of chase,
the cells were stained with anti-CD8 and analyzed by FACS. pH values were
determined for CD8+ and CD8– splenic DCs populations by FACS as described
in Experimental Procedures.
(C) Enriched CD11c+ splenocytes were allowed to phagocytose latex beads
bearing a mixture of pH-sensitive and -insensitive dyes in the presence or
not of 10 mM DPI for 15 min and then extensively washed in cold PBS-BSA.
Cells were resuspended in complete medium containing or not 10 mM DPI
and chased for 45 min. After CD8 staining, the pH was determined by FACS
as described in Experimental Procedures.
(D) Enriched CD11c+ splenocytes were allowed to intrenalize a mixture of
pH-sensitive and -insensitive 40KD dextrans in the presence or not of 10 mM
DPI for 15 min. After washing, cells were chased for different times. After
CD8 staining, the pH was determined by FACS as described in Experimental
Procedures.
Data show mean ± SEM from triplicates values and are representative of three
or more independent experiments.Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc. 545
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was already lower than 6, and acidified to reach 5.5 after 2 hr of
endocytosis. In the DCs from NOX2-defecient mice (Figure 1B,
right) or in WT DCs in the presence of DPI (Figure 1D), the endoso-
mal pH in CD8+ DCs was decreased to values similar to the ones
found in CD8– DCs. Neither DPI, nor the absence of NOX2,
affected the endosomal pH in CD8– DCs. We conclude that
NOX2 alkalinizes phagosomes and endosomes selectively in
CD8+, but not in CD8–, spleen DCs. In the absence of NOX2,
both DC subpopulations display similar pH in their endocytic
and phagocytic pathways.
CD8+ DC Crosspresentation Capacity Is Lost
in the Absence of NOX2 Activity
The high crosspresentation ability of CD8+ DCs is due both to the
phagocytic receptors they express (Iyoda et al., 2002; Schulz and







Figure 2. Crosspresentation Ability of CD8+
DCs Is NOX2 Dependent
(A) CD8+ and CD8– DCs having phagocytosed one
single OVA-coated latex bead were sorted by
FACS. Equal numbers of the two DC subpopula-
tions were then incubated with CFSE-labeled
OVA-specific transgenic T cells (OT-I) and cross-
presentation was assessed through T cell prolifer-
ation (as evaluated by CFSE staining).
(B) A control of OVA peptide (SIINFEKL, the
minimal peptide already processed) presentation
was performed with the two DC populations after
sorting.
(C and D) CD8+ and CD8– DCs from WT mice (C)
and Cybb/ mice (D) were sorted and incubated
with different concentrations of OVA for 45 min.
After washing, cells were incubated with CFSE-
labeled OVA-specific transgenic T cells (OT-I)
and crosspresentation was assessed through
T cell proliferation (as evaluated by CFSE staining).
(E and F) Sorted CD8+ and CD8– DCs from WT
mice (E) and Cybb/ mice (F) were incubated
with different concentration peptide control for
45 min. After washing, cells were incubated with
CFSE-labeled OVA-specific transgenic T cells
(OT-I) and presentation of minimal peptide was
assessed through T cell proliferation.
antigen processing (Dudziak et al., 2007;
Schnorrer et al., 2006). CD8+ and CD8
DCs that have phagocytosed one single
ovalbumin-coated bead were FACS
sorted (Figure S1 available online) and
crosspresentation was assayed with
OVA-specific OT-I T cells. As shown in
Figure 2A, CD8+ DCs crosspresented
OVA more efficiently than did CD8– DCs,
although both subpopulations presented
the synthetic peptide with similar efficien-
cies (Figure 2B).
Because pH regulation and protein
degradation are intimately related and
considering that CD8+ and CD8– DCs
display different pH in their internalization pathways, we next
analyzed proteolytic degradation in the two DC subpopulations.
Degradation of OVA was followed in vitro on purified CD8+ and
CD8– DCs after different times of internalization via immunoblot
analysis. As shown in Figures S2A and S2B, CD8– DCs degraded
internalized OVA more efficiently than did CD8+ DCs, suggesting
that CD8+ DCs display reduced activity of endolysosomal prote-
ases, as compared to CD8– DCs. In order to measure the phago-
somal proteolytic activity directly, phagosomes were isolated after
1 hr of phagocytosis from purified CD8+ or CD8– DCs, and the
activity of lysosomal enzymes at two different fixed pHs (7.4 and
6.5, the actual pH found in CD8+ and CD8– phagosomes, respec-
tively) was quantified with synthetic fluorescent substrates. As
shown in Figure S2C via a mixture of substrates specific for
cathepsins B-L, L, H, G, and asparagine endopeptidase (AEP),
the proteolytic activity at pH 6.5 was higher than at pH 7.4 in
both phagosomes from CD8+ and CD8– DCs. As expected, the546 Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc.
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on the pH. At the physiological pH values in phagosomes from
CD8+ (7.4) and CD8– (6.5) DCs (see the asterisk in Figure S2C),
phagosomes from CD8– DCs showed stronger proteolytic activity
than did phagosomes from CD8+ DCs. The activity of cathepsin S
(CatS), in contrast, was higher in phagosomes from CD8+ than
from CD8– DCs, especially at pH 7.4, the optimal pH for this
enzyme (Claus et al., 1998) (Figure S2D). Consistently, the expres-
sion of CatS was also higher in CD8+ than in CD8– DCs (Figures
S2E and S2F). We conclude that the proteolytic activity in phago-
somes from CD8+ and CD8– DCs is regulated by the pH and that at
their physiological pH, the overall proteolytic activity is superior in
phagosomes from CD8– DCs, whereas the activity of CatS is






Figure 3. NOX2 Activity Is Differentially
Regulated in Spleen DC Subtypes
(A) Total ROS production in purified DCs subpopu-
lations from WT (pretreated or not with 10 mM DPI)
or Cybb/ mice upon stimulation with 0.5 mg/ml
PMA was measured over time via luminol-ampli-
fied chemiluminiscence assay.
(B) gp91phox was detected in whole-cell lysates
from purified CD8+ and CD8– DCs by immunoblot.
a-actin was used as a loading control. Densitom-
etry quantification normalized as percentage of
CD8+ DC level of five different experiments is
shown in the lower panel.
(C and D) Enriched CD11c+ spleen DCs from WT
mice (C) or gp91phox-deficient mice (D) were
allowed to phagocytose latex beads coupled to
dihydrorhodamine 123 (DHR) for a 15 min pulse
and 45 min chase in the presence or absence of
PMA . Phagosomal oxidation in CD8+ and CD8–
subtypes was detected by FACS as described in
Experimental Procedures. A set of WT cells was
pretreated with DPI as negative control. Data
show mean ± SEM from triplicate values.
(E and F) gp91phox and p47phox were detected by
immunofluorescence after 1 hr of phagocytosis in
purified CD8+ (E) and CD8 DCs (F) via confocal
microscopy.
Data are representative of three or more indepen-
dent experiments.
In order to address whether the unique
capacity of CD8+ DCs for crosspresenta-
tion is due to their pH, we subsequently
tested OVA crosspresentation in the
different DC subsets from NOX2-deficient
spleens. As expected, in WT mice, CD8+
DCs crosspresented OVA much more effi-
ciently than did CD8– DCs (Figure 2C).
NOX2-deficient CD8+ DCs, however, lost
their capacity for OVA crosspresentation
(Figure 2D), although the presentation of
the minimal peptide was not affected
(Figures 2E and 2F). The low levels of
crosspresentation observed in CD8– DCs
were also not affected by the absence of
NOX2 activity (Figures 2C and 2D). Thus,
efficient crosspresentation in CD8+ DCs
requires active NOX2. In the absence of NOX2, both DC subtypes
crosspresent OVA with similar low efficiencies.
Subcellular Control of NOX2 Assembly
In contrast to CD8+ DCs, the absence of NOX2 activity in CD8–
DCs affected neither the phagosomal pH nor crosspresentation.
The simplest explanation for this lack of effect is that NOX2 is not
expressed or not active in CD8– DCs. In order to address this
possibility, we measured the total cellular ROS production by
CD8+ and CD8– DCs. We used the conventional luminol-based
assay and PMA as stimulus, which induces strong ROS produc-
tion. Surprisingly, total ROS production is much stronger in CD8–
than in CD8+ DCs (Figure 3A). Both DC subsets from Cybb/ or
DPI-treated WT DCs fail to show any activity, confirming thatImmunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc. 547
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DCs express higher amounts of gp91phox, as detected by
immunoblot (Figure 3B).
To measure the phagosomal production of ROS, we used
dihydrorhodamine (DHR, a nonfluorescent dye that becomes
fluorescent upon oxidation) bound to latex beads and FACS anal-
ysis, as described previously (Savina et al., 2006). ROS produc-
tion in phagosomes followed a very different pattern. After 1 hr
of phagocytosis, phagosomal ROS was undetectable in CD8–
DCs, whereas effective ROS activity was found in phagosomes
from CD8+ DCs (Figure 3C). Treatment with PMA (which activates
all cellular NOX2) increased ROS production in CD8+ DC phago-
somes, but it had no effect on phagosomal ROS in CD8– DCs,
showing the inherent inability of this DCs subtype to produce
ROS in the lumen of their phagosomes. As expected, ROS
production in CD8+ DC phagosomes was inhibited by DPI
(Figure 3C). In CD8+ DCs from Cybb/ mice, phagosomal ROS
generation was undetected, confirming that the oxidation of
DHR in those phagosomes is due to the activity of NOX2. We
conclude that in spite of the high amounts of NOX2 expression
and total ROS production, CD8– DCs are not competent for
ROS generation in phagosomes. CD8+ DCs, in contrast, display
relatively low total NOX2 activity, but strong phagosomal ROS
production, as compared to CD8– DCs.
To analyze the mechanism of this difference in phagosomal
ROS production, we analyze the recruitment of the cytosolic
subunit p47phox to phagosomal membranes in the two DC
subpopulations. Confocal immunofluorescence images revealed
a clear labeling of phagosomal membranes for gp91phox and
p47phox in CD8+ DCs, indicating effective assembly of active
NOX2 on phagosomes (Figure 3E). In CD8– DCs, gp91phox
was present both at the plasma membrane and at the membrane
of phagosomes (Figure 3F). Nevertheless, p47phox was not
detected around phagosomes in CD8– DCs, indicating that
CD8– DCs fail to assemble NOX2 at the membrane of phago-
somes (Figure 3F). These results indicate that the lack of ROS
production in phagosomes in CD8– DCs is due to their inability
to assemble the cytosolic subunits of the NOX2 complexes on
their phagosomal membranes.
Rac1 and Rac2 Expression and Subcellular Distribution
in CD8+ and CD8– DCs
Why, then, do CD8– DCs fail to assemble NOX2 complexes on
phagosomes? We showed previously that phagosomal NOX2
activity is dependent on Rab27a. However, in the absence of
Rab27a, the total NOX2 activity was also decreased (Jancic
et al., 2007). Even though the expression of Rab27a was slightly
higher in CD8+ DCs (Figures S3A and S3B), because of the high
total NOX2 activity CD8– DCs (Figure 3A), a role for Rab27a in
the differences observed between the two DC subpopulations
is unlikely. We therefore turned to other potential regulators of
NOX2 subcellular assembly. Rac proteins are essential for recon-
stituted oxidase activity in vitro and in vivo, as revealed initially by
chronic granulomatous disease (CGD, where NOX2 activity is
absent) in patients bearing mutations in Rac GTPases (Bokoch,
2005; Bokoch and Diebold, 2002; Williams et al., 2000). Previous
reports suggested that the two main Rac isoforms, Rac1 and
Rac2, may also influence the intracellular sites (phagosomes
versus plasma membrane) of NOX2 assembly in neutrophils548 Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc.and macrophages (Michaelson et al., 2001; Werner, 2004;
Yamauchi et al., 2004).
To determine a possible role for Rac proteins in the differential
NOX2 assembly in CD8+ and CD8– DCs, we first analyzed Rac
expression. As shown in Figures 4A and 4B, CD8+ DCs display
higher total Rac expression, as detected with an antibody that
recognizes both isoforms. Strikingly, a Rac1-specific antibody
revealed similar expression in the two cell types (Figures 4A
and 4B, right), suggesting that CD8+ DCs express increased
amounts of Rac2. Because all the Rac2 antibodies tested failed
to reveal Rac2 in DCs extracts by immunoblot, we used intracel-
lular FACS labeling. As shown in the fluorescence intensity
histograms in Figure 4C, Rac2 labeling is higher in CD8+ than in
CD8– DCs. DCs from Rac2-deficient mice displayed very low
amounts of fluorescence, controlling for the specificity of the
labeling (Figures 4C and 4D). Intracellular FACS labeling with
the antibodies specific for total Rac and for Rac1 confirmed
that the total amounts of Rac are higher in CD8+ DCs, whereas
the expression of Rac1 is similar in the two cell types
(Figure S4). These results show that the Rac2/Rac1 ratio is higher
in CD8+ than in CD8– DCs.
The subcellular distribution of the two Rac isoforms was also
distinct in DCs after 1 hr of phagocytosis. Rac1 was detected
on disperse intracellular structures, at the plasma membrane,
and around phagosomes (Figure 4E) in both CD8+ and CD8–
DCs (the presence of Rac1 at the plasma membrane was more
evident in CD8– DCs). The distribution of Rac2 in the two DC
subpopulations, in contrast, was very different. In CD8+ DCs,
Rac2 strongly accumulated around phagosomes, whereas it
shows a disperse distribution, and no phagosomal accumula-
tion, in CD8– DCs (Figure 4F). We conclude that the two Rac iso-
forms are differentially expressed and distributed in CD8+ and
CD8– DCs. Rac2 concentrates selectively on CD8+ DC-phago-
somes, suggesting that it may somehow be involved in phagoso-
mal function in this DC subpopulation.
The Assembly and Activation of NOX2
in CD8+ DC-Phagosomes Is Rac2 Dependent
In order to analyze the role of Rac2 in the assembly and activation
of NOX2, CD8+ and CD8– DCs were purified from Rac2-deficient
mice. Rac2-deficient DCs were phenotypically identical to WT
DCs (as judged by the surface expression of CD11c, CD80-86,
and CD40, not shown). The total production of ROS was partially
decreased in CD8– DCs, and slightly diminished in CD8+ DCs, as
compared to WT DCs (Figure 5A). In contrast, the phagosomal
activity of NOX2, which was only detectable in WT CD8+ DCs,
was decreased to background expression in the absence of
Rac2 (Figure 5B). Therefore, Rac2 is dispensable for total ROS
production, but absolutely required for phagosomal ROS gener-
ation, suggesting that Rac2 may selectively control the phagoso-
mal assembly of NOX2 in CD8+ DCs.
We addressed this possibility by analyzing the subcellular
distribution of gp91phox and p47phox by using confocal micros-
copy. Accumulation of gp91phox was observed around phago-
somes in WT CD8+ DCs (Figures 3E and 5C), with virtually no
labeling at the plasma membrane. Consistent with the sustained
production of ROS in CD8+ DC phagosomes (Figure 3C),
p47phox was effectively recruited to the phagosomal gp91phox
(Figure 5C). In contrast, in Rac2-deficient CD8+ DCs, gp91phox
Immunity
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p47phox around phagosomes was observed, even when several
confocal planes were analyzed (Figure 5D). In Rac2-deficient
CD8– DCs, we observed no differences, as compared to their
WT counterparts, in the subcellular distribution of gp91phox
and p47phox (Figure S5). We conclude that Rac2 controls the
phagosomal assembly and activation of NOX2 complex selec-
tively in CD8+ DCs. In the absence of Rac2 (when only Rac1 is
present), NOX2 assembly in phagosomes is not observed.
Interestingly, in the absence of any stimuli, gp91phox was
mainly present at the plasma membrane in WT CD8– DCs and
on disperse cytoplasmic structures in CD8+ DCs. The distribution
of these two NOX2 subunits was not affected in Rac2/ CD8–
DCs (Figure 5E, top), but a strong redistribution of gp91phox
from the cytoplasm to the plasma membrane was observed in
CD8+ DCs lacking Rac2 (Figure 5E, bottom). Therefore, at the






Figure 4. Expression and Subcellular Local-
ization of Rac Isoforms Vary between CD8+
and CD8– DCs
(A) Total Rac (top) and Rac1 (middle) were detected
in whole-cell lysates from purified CD8+ and CD8–
DCs by immunoblot. a-actin was used as a loading
control (bottom).
(B) Densitometry quantifications normalized as
percentage of CD8+ DC amounts in five different
DC purifications are shown.
(C) Typical FACS profiles for Rac2 intracellular
staining (and isotype antibody control) for each
cell type from one DC purification are shown.
(D) Quantification of Rac2 (and isotype control)
intracellular staining of CD11c+ purified spleen
cells from three different mice. Data are represen-
tative of three independent experiments.
(E and F) Confocal images of immunofluorescent
detection of Rac1 (C) and Rac2 (D) on purified
CD8+ and CD8– DCs after 1 hr phagocytosis of
latex beads are shown.
CD8– and CD8+ DCs was indistinguish-
able. As expected, p47phox remained
mainly cytosolic in all cases, because
there is almost no active NOX2 under
these steady-state conditions. Together,
these results show that Rac2 was essen-
tial to the phagosomal assembly and
ROS production in CD8+ DCs, whereas
Rac1 directed the assembly of the
complex to plasma membrane in both
CD8– DCs and Rac2-deficient CD8+ DCs.
Rac2 Controls the Phagosomal pH
and Crosspresentation in DCs
Contrary to our expectations, the phago-
somal pH was only slightly decreased (by
0.5 pH units) in CD8+ DCs (Figure S6A) or
in bone marrow-derived DCs (not shown)
from Rac2-deficient mice. To investigate
the possible reasons of this low degree
of acidification in spite of the absence of
ROS production in phagosomes, we analyzed the expression of
the V-ATPase in the Rac2-deficient DCs. Strikingly, the expres-
sion of the Vo membrane subunit of the V-ATPase, an essential
player in phagosome acidification, was strongly decreased in
Rac2/ DCs (Figure S6B). Downmodulation of the V-ATPase
could explain the low degree of phagosomal acidification
observed in Rac2-deficient DCs, suggesting that CD8+ DCs
somehow compensate the absence of Rac2 expression by
limiting acidification through decreased expression of the
V-ATPase. Consistent with this observation, no important inhibi-
tion of crosspresentation was observed in CD8+ DCs (Figure S6C)
and BMDC (data not shown) from Rac2/ mice.
We reasoned that if CD8+ DCs indeed compensate the
absence of Rac2 by decreasing the expression of the V-ATPase,
the effect of reducing Rac2 expression directly in immature DCs
should have stronger effects on the phagosomal pH and on
crosspresentation. We therefore genetically targeted Rac2 byImmunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc. 549
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in Figure 6A, two different shRNAs targeting Rac2 inhibit the
expression of Rac2, as compared to DCs transduced with the
scramble shRNA. Rac2 depletion caused a strong inhibition of
ROS production in phagosomes (Figure 6B). Likewise, the phag-
osomal pH acidified strongly (by around 2 pH units) after 1 hr of
phagocytosis, as compared to cells infected with the scrambled
shRNA control lentivirus (Figure 6C). No inhibition of the expres-
sion of the V-ATPase was detected in the DCs infected with the
Rac2 shRNA lentivirus, as compared to the control infected
DCs (Figure S7A). Crosspresentation was assayed with latex





B Figure 5. Rac2 Controls the Phagosomal
Activity of NOX2 in CD8+ DCs
(A) Total ROS production in purified DCs subpop-
ulations from WT or Rac2/ mice was evaluated
during 90 min after PMA stimulation via a lumi-
nol-amplified chemiluminiscence assay.
(B) Enriched CD11c+ spleen DCs from WT or
Rac2-deficient mice were allowed to phagocytose
DHR-coated beads for 15 min. After washing, the
cells were chased for 45 min. Oxidation in phago-
somes in CD8+ and CD8– subtypes was detected
by FACS as described in Experimental Proce-
dures. A set of WT cells was pretreated with DPI
as negative control. Data show mean ± SEM
from triplicate values.
(C and D) gp91phox and p47phox were detected
by immunofluorescence after 1 hr phagocytosis
of latex beads on purified CD8+ and CD8– DCs
from WT (C) or CD8+ Rac2/ (D) mice. Three
different confocal planes are depicted in (D).
(E)gp91phox andp47phoxwere detectedby immu-
nofluorescence in steady-state purified CD8+ and
CD8– DCs from WT or Rac2/ mice.
Data are representative of three or more indepen-
dent experiments.
OVA. As shown in Figure 6D, crosspre-
sentation was strongly inhibited by the
Rac2 shRNAs, as compared to the control
shRNA. No effect of the shRNAs on the
presentation of the peptide was observed
(Figure 6E). In one of the experiments, the
inhibition of Rac2 expression was partially
achieved with one of the shRNAs (Rac2 # 1
construct; Figure S8A). The phagosomal
pH and crosspresentation were only
partially affected (Figures S8B–S8D) by
this shRNA, indicating that the effects of
the shRNAs on pH and crosspresentation
are a direct consequence of the amount
of Rac2 expression. In all cases, the
phagocytic capacity of the infected DCs
was not modified in absence of Rac2
(Figure S7B). Crosspresentation of soluble
OVA was alsodefective inabsence ofRac2
(Figure S9A). However, antigen presenta-
tion in the MHC class II context was not
importantly affected (Figure S9B). We
conclude that Rac2 controls ROS production in phagosomes
and endosomes, thereby preventing effective acidification of
endo-phagocytic pathway and promoting antigen crosspresen-
tation.
DISCUSSION
The functional organizationof thephagocyticpathway is a charac-
teristic of different phagocytes. Accordingly, macrophages,
neutrophils, and DCs show quite different phagosomal pathways
in terms of oxidation, pH, and degradation. Neutrophils and
macrophages have highly cytotoxic and degradative phagocytic550 Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc.
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D E
B C Figure 6. Phagosomal pH and Crosspre-
sentation Are Controlled by Rac2 in DCs
(A) DCs were infected with three different lentivirus
encoding a random sequence (Scramble) and two
different shRNA targeted to Rac2 (Rac2 # 1 and
Rac2 # 2). After selection, DCs were analyzed at
day 7 by quantitative RT-PCR to evaluate the
decreased expression of Rac2. Results are ex-
pressed as a ratio relative to GAPDH.
(B)TransducedDCs atday 7 wereallowed tophago-
cytose DHR-coated beads for 15 min. After
washing, the cells were chased for 45min. Oxidation
inphagosomes was detectedbyFACSasdescribed
in Experimental Procedures. A set of WT cells was
pretreated with DPI as negative control. Data show
mean ± SEM from triplicate values.
(C) Phagosomal pH of transduced DCs was
measured by FACS after 15 min of pulse and
30 min of chase of latex beads coated with pH-
sensitive and nonsensitive dyes. Data show
mean ± SEM from triplicate values.
(D) Crosspresentation in transduced DCs was as-
sayed via beads (dilution 1:200) coated with
different ratios of OVA/BSA protein concentra-
tions. T cell proliferation was evaluated by CFSE
staining of OVA-specific transgenic T cells (OT-I).
(E) A control with OVA peptide was done with the
same DCs. Data show mean ± SEM from triplicate
values.
Data are representative of at least three indepen-
dent lentivirus infections.Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc. 551pathways, adapted to their role in the killing of microbes and clear-
ance of apoptotic cells. DCs, in contrast, have a nonacidic, lowly
degradative phagocytic pathway, most likely devoted at
producing partial proteolytic products for immune recognition.
The present study shows that different DC populations display
different functional phagocytic organisations. Although both
subpopulations display ‘‘mild’’ phagocytic pathways as com-
pared to macrophages or neutrophils, CD8+ DCs seem to
‘‘borrow’’ certain functional features from neutrophils, whereas
the phagocytic pathway of CD8– DCs seems to be closer to
macrophages’ phagocytic pathways. The distinction between
these two phagocytic organisations relies on Rac2: in the absence
of Rac2, CD8+ and CD8– DCs are very similar in terms of phago-
somal acidification, ROS production, and crosspresentation.
The functional relevance of the existence of different myeloid
DC subpopulations is still unclear. These subpopulations express
different sets of receptors, including receptors for microorgan-
isms (lectins, PRRs, including TLRs), cytokines and chemokine
receptors, and receptors for dead cells (Edwards et al., 2003).
The different subpopulations also produce different cytokines
and chemokines and present antigens more or less efficiently
to different types of T lymphocytes (Maldonado-Lopez et al.,
2001). The heterogeneity in DC subpopulations therefore seems
to correspond to a double functional purpose. First, because they
express different phagocytic receptors, the two main spleen DC
subpopulations take up different pathogens or, more generally,
different types of particles. CD8+ DCs, for example, phagocytose
apoptotic cells much more efficiently than do CD8– DCs (Iyoda
et al., 2002; Schulz and Reis e Sousa, 2002). Leishmania, as
another example, infects CD8– DCs preferentially (Ritter et al.,
2004). Second, because they express different TLRs or T cellcostimulation molecules, and because they produce different
cytokines, different DC populations may initiate different types
of immune responses (Maldonado-Lopez et al., 1999). There is
therefore no question that myeloid DC subpopulations may
play selective roles in the initiation of adaptative immune
responses.
The specialization of different subpopulations of DCs for
antigen presentation was reported by several groups (Iyoda
et al., 2002; Pooley et al., 2001; Schulz and Reis e Sousa,
2002), but direct evidence showing that their differential presen-
tation abilities are a consequence of postinternalization events
was published only recently. Indeed, Villadangos’s group
analyzed antigen presentation to CD8+ and CD4+ T cells by
DCs from either subpopulation that had phagocytosed on
a single antigen-coupled latex bead (the cells were FACS
sorted). Even though all the DCs had internalized the same
amount of antigen, CD8+ DCs presented them more efficiently
to CD8+ T cells, whereas the opposite was found in CD8– DCs
(Schnorrer et al., 2006). Dudziak et al. (2007) showed subse-
quently that in vivo targeting of ovalbumin to the two DC subpop-
ulations with two different monoclonal antibodies also resulted in
more efficient CD8+ T cell activation by CD8+ DCs and more effi-
cient activation of CD4+ T cells by CD8– DCs. Although this group
showed that the overall expression of certain genes involved in
MHC class I versus MHC class II-restricted antigen presentation
were slightly overexpressed in the corresponding DC subpopu-
lations, no evidence that these differences were responsible for
the selectivity of antigen presentation were presented.
Our results show that the absence of expression of gp91phox
or Rac2, both causing a loss of phagosomal ROS production
in CD8+ DCs, also abolish the high efficiency of antigen
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and Rac2 deficiencies caused the endophagocytic pathway of
CD8+ DCs to resemble that of CD8– DCs (i.e., reduced ROS
production and increased acidification). As a consequence,
CD8+ DCs failed to crosspresent antigens efficiently, indicating
that high ROS production and low acidification in endosomes
and phagosomes are required for efficient crosspresentation.
These results establish that the functional organization of DCs’
internalization pathway critically controls their crosspresentation
capacities.
How do the two splenic DC subpopulations regulate the
subcellular localization of ROS production? Rac proteins have
previously been shown to participate in the assembly of the
NADPH oxidase in neutrophils and macrophages (Bokoch and
Zhao, 2006). In mammalian cells, three Rac isoforms have
been identified: Rac1, Rac2, and Rac3. Rac1 and Rac3 are
widely expressed whereas Rac2 expression is highly restricted
to hematopoietic cells (Werner, 2004). In neutrophils, Rac-
dependent NOX2 activation is selective for Rac2, even though
these cells express both Rac1 and Rac2 at similar amounts as
in mice (unlike human neutrophils, which express predominantly
Rac2) (Werner, 2004). In contrast, in human and murine macro-
phages, Rac1 is the most abundant Rac isoform. Rac1 and
Rac2, however, display extremely high amino acid identity
(92%). The main difference between them is in the hypervariable
C-terminal tail, which is believed to confer distinct localization of
small GTPases and specificity for ROS production (Yamauchi
et al., 2004). Indeed, previous reports showed that Rac1 has
a preferential localization to the plasma membrane and Rac2
localizes mainly to intracellular membranes (Filippi et al., 2004;
Michaelson et al., 2001; Yeung et al., 2008). In DCs, we observed
that Rac1 was mainly present at the plasma membrane (with
some faint labeling around phagosomes), whereas Rac2 was
found exclusively on phagosomes.
Because it is well known that Rac1 is essential for the phagocy-
tosis process and regulates the actin cytoskeleton (Greenberg,
1999; Niedergang and Chavrier, 2005), its presence around
phagosomes in DCs is not surprising. The observation that
Rac1 is present on CD8– DC phagosomes, which are incompe-
tent to assemble and activate NOX2, suggests that this GTPase
is not involved in phagosomal ROS production. Indeed, in
Rac2-deficient DCs (which express normal amounts of Rac1),
the phagosomal assembly of NOX2 was not observed, confirm-
ing that Rac1 fails to mediate the assembly NOX2 on phago-
somes. In contrast, in Rac2-deficient DCs, the plasma membrane
assembly of NOX2 was more evident than in the WT, suggesting
that the two Rac isoforms somehow compete for the assembly at
these two alternative subcellular locations. These experiments
also show that CD8+ DCs express all the machinery required
for the plasma membrane assembly of NOX2. Nevertheless, it
is also possible that the reason why CD8– DCs (which also
express Rac2, although at lower amount) fail to assemble
NOX2 on phagosomes is related to the expression of Rac effec-
tors. The selective expression of Rac1-specific GEFs (such as
b-Pix) (ten Klooster et al., 2006) or the lack of Rac2-specific effec-
tors, GAPs, and/or GEFs (P-Rex1 and Vav1 are Rac GEFs that
favor activation of Rac2 versus Rac1) (Dong et al., 2005; Ming
et al., 2007; Welch et al., 2002) could contribute to NOX2
assembly at different sites. Indeed, we found that Vav1 expres-552 Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc.sion is higher (by at least 2-fold) in CD8+ than CD8– DCs (not
shown). Accordingly, it has recently been shown that Vav is
required for both maintaining the phagosomal pH in DCs and
for OVA crosspresentation (Graham et al., 2007). It is also
possible that under certain conditions, such as stimulation of
particular TLRs, the activation of the two Rac isoforms is modi-
fied, inducing changes in the phagosomal fate and in crosspre-
sentation. Such a regulation of the phagosomal function could
explain why CD8– DCs can crosspresent antigens in vivo after
injection of OVA immune complexes (Pooley et al., 2001). Never-
theless, our results show that after stimulation, CD8– DCs
produce ROS at the plasma membrane, suggesting that extracel-
lular ROS production may be involved in some other biological
process, such as inflammation, as shown in macrophages (For-
man and Torres, 2001).
Interestingly, all our observations for the regulation of the
phagosomal pH are also valid for endosomes. This is quite
surprising because phagocytosis is known to activate NOX2,
but this was not the case for endocytosis (a constitutive
process). Several different possibilities could account for these
observations. First, DCs, in contrast to other phagocytes, could
display low basal NOX2 assembly on endosomes. Indeed, we
also showed that the NOX2 assembles on endosomes in human
DCs (Mantegazza et al., 2008). Second, NOX2 activation could
occur selectively on macropinosomes, which are known to
form constitutively in DCs, and not in macrophages. Finally,
very small LPS contamination in the dextrans (which, however,
fail to cause complete DC activation) used to measure endoso-
mal pH could eventually cause the activation of ROS.
The most direct, but not the only, explanation for the critical role
of ROS production and the pH in crosspresentation, relates to the
proteolytic activity in the endocytic and phagocytic pathways of
DCs. Several groups showed previously that the proteolytic
activity in DC-lysosomes (Trombetta et al., 2003) and -phago-
somes (Lennon-Dumenil et al., 2002) is lower than in macro-
phages. Limited proteolysis is in part due to low levels of
expression of certain proteolytic enzymes in DCs (Delamarre
et al., 2005). Likewise, a recent paper shows slight differences
in the levels of mRNA encoding several cathepsins in between
CD8+ and CD8 DCs (Dudziak et al., 2007). This is not, however,
the case for all proteases, as shown by the fact that CatS is clearly
overexpressed in CD8+ DCs. Interestingly, and consistent with
our pH measurements in DC phagosomes and endosomes,
CatS has optimal activity at neutral pH, in contrast to many other
lysosomal proteases. According to this, CD8+ phagosomes dis-
played higher CatS activity than phagosomes from CD8– DCs,
especially at 7.4. Overall, however, the proteolytic activity of the
rest of proteases tested was lower in CD8+ than in CD8– DCs,
in part at least due to the pH differences. Taken together, our find-
ings show that the differences in the phagocytic environment
between CD8+ and CD8– DCs are complex. Not only is the
pH regulated differentially, but the relative abundance and the
activity of different cathepsins are also selectively controlled.
Whereas the phagosomes from CD8– DCs are somehow similar
to phagosomes from macrophages (although probably less
acidic and less degradative), phagosomes from CD8+ DCs are
very different, with low levels and low activity of most cathepsins,
whereas CatS is both very abundant and very active at the high
pH found in CD8+ DC phagosomes. The observation that the
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presentation is maintained at the optimal values for CatS, and not
for other proteases, suggests that CatS is a critical player in
antigen breakdown for crosspresentation (as already suggested
by Shen et al. [2004]). Interestingly, the activity of this protease
decreases with the reduction of the peptide length (Lutzner and
Kalbacher, 2008), indicating that CatS is a self-limiting protease
and may be specialized in the production of relatively long
peptides. Besides the proteolytic activity, phagosomal ROS
production and high pH may favor other intracellular steps
involved in crosspresentation, such as peptide loading (if it can
occur in phagosomes, which is still unclear) or antigen export to
the cytosol.
This study provides evidence that the differentiation of myeloid
DC subpopulations implicates specializations of their endopha-
gocytic pathways. Such a degree of control of the internalization
pathway suggests an evolutionary pressure on this particular
function. If the main purpose of this phagocytic specialization
was related to crosspresentation (which we do not know, but
is suggested by our results), these results would support a critical




C57BL/6 mice (WT) and C57BL/6 recombination activating gene 1-deficient
OT-1 TCR (Va2, Vb5) transgenic mice were obtained from Charles River Labo-
ratories and Centre de Distribution, Typage et Archive Animal (Orleans,
France). Cybb/ mice (C57BL/6 background) were originally provided by
M. Mallat (Hoˆpital de la Salpeˆtriere, Paris) and raised in the Curie Institute
animal facility. Rac2/ mice (C57BL/6 background) (Roberts et al., 1999)
were provided by D. Williams (Cincinnati Children’s Research Foundation,
Cincinnati, OH) and V. Tybulewicz (National Institute for Medical Research,
London, UK). All mice were used according to the guidelines and regulations
of the French Veterinary Department.
Crosspresentation Assay
For crosspresentation assays with soluble OVA (Worthington Biochemical
Corporation), sorted DCs were incubated with different concentrations of
soluble OVA or different concentrations of the minimal peptide as control of
surface MHC class I amount. 45 min later, cells were washed three times
with PBS plus 0.5%BSA and cocultured with CFSE-OT-I T cells for 3 days.
For monitoring T cell proliferation, diminution of CFSE staining on TCR+-
CD8+ population was measured by FACS. Alternatively, OVA-BSA-coated
beads were prepared by attaching different ratios of OVA and BSA protein
concentrations (OVA 10 mg ml1 alone; OVA 3.33 mg ml1/BSA 6.67 mg ml1;
OVA 1.11 mg ml1/BSA 8.89 mg ml1; OVA 0.37 mg ml1/BSA 9.63 mg ml1;
and BSA 10 mg ml1 alone) to 3 mm latex beads by passive adsorption in
PBS at 4C ON, and extensive washed in PBS. DCs were incubated with
3 mm OVA-BSA-coated latex beads or with the specific OVA peptide 257-
264 (SIINFEKL) (Neosystem) for 45 min. After washing with PBS plus
0.5%BSA and cocultured with CFSE-OT-I T cells for 3 days, T cell proliferation
was assayed by FACS.
For some experiments, OVA-Biotin was conjugated to streptavidin fluores-
cent latex beads (Streptavidin fluoresbrite YG Microspheres 1.0 micron from
Polyscience, Inc.) as described elsewhere (Schnorrer et al., 2006). After isola-
tion from spleens, enriched CD11c+ cells were allowed to phagocytose OVA-
Biotin-coated fluorescent latex beads for 15 min. After extensive washing, the
cells were chased for 45 min more. Phagocytosis was stopped by adding cold
PBS-BSA. The cells were then stained with anti-CD11c and anti-CD8 and
subsequently sorted in CD8+ and CD8– populations for cells that have phago-
cytosed one latex bead. Equal numbers of the two DC subpopulations were
then incubated with CFSE-labeled OVA-specific transgenic T cells (OT-I)and crosspresentation was assessed through T cell proliferation (as evaluated
by CFSE staining).
Intracellular Staining
Purified CD11c+ cells from spleens were staining with an FITC anti-CD8 at 4C.
After washing, the cells were treated for intracellular staining according to
manufacturer procedures with the kit Foxp3 Fixation/Permeabilization
concentrate and diluent (eBioscience). Anti-Rac, anti-Rac1, anti-Rac2, and
isotype antibodies were used at 1.5 mg/ml and the secondary antibodies (Alexa
647 labeled) at 1 mg/ml. The cells were subsequently analyzed by FACS.
Immunofluorescence Assay
For the detection of Rac1, Rac2, gp91phox, and p47phox, purified DCs were
pulsed or not with latex beads (Polysciences, Inc) (dilution 1:100) for 15 min at
37C. After extensive washing with cold PBS, the cells were placed on poly-L-
lysine-coated glass coverslips at 37C in an atmosphere of 5% CO2 during
a short period. Complete medium was added and cells were chased for
another 45 min. After washing, cells were fixed with 2% paraformaldehyde
for 10 min at 4C and quenched by adding 0.1 M glycine. Cells were permea-
bilized in PBS-0.05% saponin-0.2% BSA for 20 min, washed, and then incu-
bated with the primary and secondary antibodies. After labeling and extensive
washing with PBS-0.05% saponin-0.2% BSA, the coverslips were mounted
with Fluoromount G and the cells were analyzed by confocal microscope
(Zeiss confocal microscope [LSM Axivert 720], 63 3 1.4 NA oil immersion
objective). For z-stack acquisition, several images (step 0.3 mm) to cover
most of the cell volume were acquired.
pH Measurement
pH in phagosomes was determined as described previously (Savina et al.,
2006). In brief, 3 mm polybeads amino were covalently coupled with 1 mg/ml
FITC (pH sensitive) and 1 mg/ml FluoProbes 647 (pH insensitive) in the pres-
ence of sodium hydrogen carbonate buffer at pH 8 for 2 hr at room tempera-
ture. After extensively washing with glycine 100 mM, the beads were
suspended in PBS. Enriched CD11c+ spleen DCs were pulsed in a small
volume CO2-independent medium without serum with the coupled beads for
15 min in a water bath at 37C and then extensively washed (2 times) in a large
volume of cold PBS-0.5% BSA. In each wash, the cells were centrifuged at
1000 rpm for 4 min to pull down only the cells avoiding the no internalized
beads. After washing, the cells were resuspended in complete medium incu-
bated at 37C (‘‘chased’’) in the incubator for the indicated times and immedi-
ately placed on ice. CD8a (1 mg/ml) staining was done and then the cells were
analyzed by FACS, via a gating FSC-CD8a+ selective for cells that have phago-
cytosed one latex bead. The ratio of the mean fluorescence intensity (MFI)
emission between the two dyes was determined. Values were compared
with a standard curve obtained by resuspending the cells that had phagocy-
tosed beads for 30 min at fixed pH (ranging from pH 5.5 to 8) and containing
0.1% Triton X-100 for 8 min. The cells were immediately analyzed by FACS,
to determine the emission ratio of the two fluorescent probes at each pH. Alter-
natively, phagosomal pH was measured in Rac2-depleted BMDC. For this
purpose, after 15 min pulse and 30 min chase, infected BMDC were placed
on ice and stained for CD11c. The FACS analysis for pH measurement was
done gating CD11c+ cells.
pH in endosomes was determined as follows. Enriched CD11c+ spleen DCs
were pulsed in a small volume CO2-independent medium containing a mix of
40,000 MW Dextran fluorescein (5 mg/ml) and 40,000 MW Dextran Alexa 647
(5 mg/ml) for 7 min in a water bath at 37C and then extensively washed in
a large volume of cold PBS-0.5% BSA. After washing, the cells were resus-
pended in complete medium incubated at 37C (‘‘chased’’) in the incubator
for the indicated times and immediately placed on ice. To determine the endo-
cyting population, a control at 4C during pulse and chase was done. CD8a
(1 mg/ml) staining was done and then the cells were analyzed by FACS, via
a gating FSC-CD8a+ selective for cells that have internalized dextrans. The
ratio of the mean fluorescence intensity (MFI) emission between the two
dyes was determined. Values were compared with a standard curve obtained
by resuspending the cells that had phagocytosed beads for 30 min at fixed
pH (ranging from pH 5.5 to 8) and containing 0.1% Triton X-100 for 8 min.
The cells were immediately analyzed by FACS to determine the emission ratio
of the two fluorescent probes at each pH.Immunity 30, 544–555, April 17, 2009 ª2009 Elsevier Inc. 553
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Detection of Phagosomal ROS Production via a Fluorescent Probe
3 mm polybeads amino were covalently coupled with DHR (1 mg/ml) and
FluoProbes 647 (1 mg/ml) in the presence of sodium hydrogen carbonate
buffer at pH 8 for 2 hr at room temperature. After extensively washing with
glycine 100 mM, beads were resuspended in PBS. Enriched CD11c+ spleen
DCs were pulsed in a small volume CO2-independent medium containing
DHR-coupled beads during 15 min and then extensively washed in a large
volume of cold PBS-0.5%BSA. In each wash, the cells were centrifuged at
1000 rpm for 5 min. After washing, the cells were resuspended in complete
medium incubated at 37C (‘‘chased’’) in the incubator for the indicated times
and immediately placed on ice. CD8a (1 mg/ml) staining was done and then the
cells were analyzed by FACS, via a gating FSC/CD8+ selective for cells that
have phagocytosed one latex bead. Because mean fluorescence intensity
(MFI) of FluoProbes 647 is constant over time, only the variation of DHR MFI
was determined. For DPI assay, cells were incubated in the presence of
5 mM DPI for 30 min before and during the 15 min pulse.
Alternatively, phagosomal oxidation was measured in Rac2-depleted
BMDC. For this purpose, after 15 min pulse and 30 min chase with DHR/Fluop-
robes 647-coated beads, infected BMDC were placed on ice and stained for
CD11c. The FACS analysis was done gating CD11c+ cells.
Measurement of Total NOX2 Activity by Chemiluminiscence
53 105 purified CD8+ DCs and CD8 DCs were resuspended in 200 ml of CO2-
independent medium containing 10 mM luminol (the probe which releases
energy as visible light upon oxidation) and 5 units of horseradish peroxidase.
Cell suspensions were preheated to 37C in the thermostated chamber of
the luminometer (Berthold Centro LB 960) and allowed to stabilize. Changes
in chemiluminiscence were measured over the indicated times. An injection
of 0.5 mg/ml PMA after 5 min was used as stimulus.
Lentiviral shRNA Knock Down of Rac2
Generation and Titer of Lentivirus
Plasmids encoding lentiviruses expressing shRNAs were obtained from the
library of The RNAi Consortium (TRC) (Moffat et al., 2006). Plamids were puri-
fied with the QiaPrep miniprep kit (QIAGEN, Valenica, CA). Plasmids were then
transfected into HEK293T cells with a three-plasmid system to produce lenti-
virus with a very high titer of 107 CFU/ml (Moffat et al., 2006; Naldini et al.,
1996). We initially tested five different hairpins directed against Rac2 and
compared their efficiency by RT-PCR against a control hairpin (a scramble
sequence against GFP). We found Rac2#2 (target sequence GCCAAGT
GGTTCCCTGAGGTA) and Rac2#1 (target sequence GATTCAGTCAAGTAC
TTGGAA) to be the most efficient.
Dendritic Cell Infection
Mouse bone marrow cells were plated on a 96-well plate (round bottom) at
a concentration of 105 cells per well with 200 ml of GM-CSF medium. After
48 hr, the medium was carefully removed without disturbing the cells at the
bottom. We added 10 ml of virus and the pellet was resuspended 3 to 5 times.
40 ml of polyB in GM-CSF medium were added (1:1000 final concentration)
and we centrifuged the plate at 2200 rpm for 90 min at 37C. After the centrifu-
gation, all medium was removed and 200ml/well of fresh GM-CSF medium were
added. The plates were incubated for 48 hr and then the cells were selected with
5 mg/ml of puromycin. Cells were collected for analysis 72 hr after selection.
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